Fonar Corp (FONR) — Titan Protect Analysis

FONR

Fonar Corp

Healthcare · ·

$19.09

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$120M

Total market value of the company

Trailing P/E

19.09

Reasonably valued

Forward P/E

N/A

Based on estimated future earnings — lower means cheaper

Rev Growth

-2.6%

Year-over-year revenue change

Profit Margin

6.4%

How much profit the company keeps from each dollar of revenue

ROE

5.5%

Return on equity — how efficiently it uses shareholder money

Analyst Target

N/A

Recommendation

NONE

Consensus view from ? analysts covering this stock

About Fonar Corp

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such a

https://www.fonar.com

Country: United States Employees: 535 Industry: Diagnostics & Research

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.460

Positive but modest risk-adjusted returns

Kelly Fraction

0.0078

Marginal edge — very small allocation suggested

Calmar Ratio

0.298

Drawdown risk outweighs the returns — higher risk profile

Annual Return

10.5%

Historical annualised return based on price data

Max Drawdown

-35.1%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.96

Less volatile than the market — more defensive

52W High

$19.16

0% below the year high

52W Low

$13.62

40% above the year low

Avg Volume

81,065

Average daily shares traded — higher means easier to buy and sell

Short Ratio

1.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$1.00

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

23.61

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

40.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

9.2%

Profit from core operations before interest and tax

Free Cash Flow

$1M

Positive — the business generates more cash than it spends

Revenue (TTM)

$105M

Total revenue over the last 12 months

Net Income

$6M

Profitable — the bottom line is positive

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go